Toggle Main Menu Toggle Search

Open Access padlockePrints

HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency

Lookup NU author(s): Dr Ugo OfforORCiD, Dr Sujith Samarasinghe, Dr Kevin Windebank, Professor Mary Slatter, Professor Andrew GenneryORCiD, Dr Christopher Bacon, Dr Simon BomkenORCiD



This is the authors' accepted manuscript of an article that has been published in its final definitive form by Elsevier Inc., 2020.

For re-use rights please refer to the publisher's terms and conditions.

Publication metadata

Author(s): Prunotto G, Offor UT, Samarasinghe S, Wynn R, Vora A, Carpenter B, Gowdy C, McHugh K, Windebank KP, Rovelli AM, Slatter MA, Gennery AR, Veys P, Bacon CM, Bomken S, Lucchini G

Publication type: Article

Publication status: Published

Journal: Journal of Allergy and Clinical Immunology

Year: 2020

Volume: 146

Issue: 2

Pages: 447-450

Print publication date: 01/08/2020

Online publication date: 01/05/2020

Acceptance date: 26/03/2020

Date deposited: 20/05/2020

ISSN (print): 0091-6749

ISSN (electronic): 1097-6825

Publisher: Elsevier Inc.


DOI: 10.1016/j.jaci.2020.03.043

PubMed id: 32371070


Altmetrics provided by Altmetric